News
In his new role with the FDA, Dr. Vinay Prasad will oversee the regulation of costly drugs, including vaccines, gene ...
Prasad's appointment marks the latest addition of a medical skeptic and critics of COVID-19 policies to federal health ...
The U.S. Food and Drug Administration has named Vinay Prasad, an oncologist who has previously criticized the FDA and was a ...
The UCSF professor and frequent YouTube poster has criticized COVID-19 vaccine mandates as well as the accelerated approval ...
FDA names Vinay Prasad to lead CBER, raising questions over biologics oversight and triggering biotech stock losses and ...
The FDA has chosen Dr Vinay Prasad, a professor at UCSF, to lead its Center for Biologics Evaluation and Research.
CBER’s new chief has argued for more stringent measures of assessing drugs for cancer and rare diseases, suggesting he might ...
Dr. Vinay Prasad, a prominent critic of the pharmaceutical industry and the Food and Drug Administration, has been named to ...
In the wake of the high-profile departure of Peter Marks, M.D., Ph.D., the FDA has a new leader for its Center for Biologics ...
The U.S. Food and Drug Administration (FDA) has chosen Dr. Vinay Prasad ... according to CNN. Prasad's appointment comes as the FDA plans to require future vaccines to be tested through placebo ...
The US Food and Drug Administration has named Dr. Vinay Prasad ... Prasad’s appointment to lead the Center for Biologics Evaluation and Research comes as the FDA says it will impose new ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results